Jonathan N Priantti

7PUBLICATIONS
26CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 22, 2024
Safety and Efficacy of Osimertinib in Patients With Non-Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis.

Jonathan N Priantti, Yu Fujiwara, Francisco Cezar Aquino de Moraes

|Oct 22, 2024
Efficacy and Safety of Anti-EGFR Therapy Rechallenge in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.

Francisco Cezar Aquino de Moraes, Anna Luíza Soares de Oliveira Rodrigues, Jonathan N Priantti

|Jul 27, 2024
Neurocognitive Adverse Events Related to Lorlatinib in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Jonathan N Priantti, Maysa Vilbert, Francisco Cezar Aquino de Moraes

|May 25, 2024
Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials.

Francisco Cezar Aquino de Moraes, Gustavo de Oliveira Almeida, Vinícius Freire Costa Alves

|May 06, 2024
Efficacy and safety of BRAF/MEK inhibitors in BRAFV600E-mutated anaplastic thyroid cancer: a systematic review and meta-analysis.

Jonathan N Priantti, Natasha Maranhão Vieira Rodrigues, Francisco Cezar Aquino de Moraes

|Dec 23, 2023
Mesenchymal-Epithelial Transition Kinase Inhibitor Therapy in Patients with Advanced Papillary Renal-Cell Carcinoma: A Systematic Review and Meta-Analysis.

Francisco Cezar Aquino de Moraes, Maysa Vilbert, Vinícius Freire Costa Alves

Pageof 2

Frequent Collaborators

6 joint publications

Francisco Cezar Aquino de Moraes

5 joint publications

Maysa Vilbert

3 joint publications

Ludimila Cavalcante

2 joint publications

Thiago Madeira